5P50AG005134-35 |
2018 |
$782117 |
5900 |
Core B - Clinical Core |
GOMEZ-ISLA, TERESA |
5P50AG005134-35 |
2018 |
$201272 |
5901 |
Core C - Data Management and Statistics |
BETENSKY, REBECCA A |
5P50AG005134-35 |
2018 |
$228639 |
5902 |
Core D - Neuropathology Core |
FROSCH, MATTHEW P |
5P50AG005134-35 |
2018 |
$161043 |
5903 |
Core E - Outreach, Recruitment and Education Core |
SPERLING, REISA A. |
5P50AG005134-35 |
2018 |
$176004 |
5904 |
Core F - Neuroimaging Core |
SPERLING, REISA A. |
5P50AG005134-35 |
2018 |
$217594 |
5905 |
Neural Correlates of Cognitive Prodromes in Neurodegenerative Dementias |
HEDDEN, JULIUS C |
5P50AG005134-35 |
2018 |
$217594 |
5906 |
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience |
GOMEZ-ISLA, TERESA |
5P50AG005134-35 |
2018 |
$207535 |
5907 |
Mouse Model of Early Alzheimers Disease |
HYMAN, BRADLEY T |
5P50AG005134-35 |
2018 |
$525952 |
5899 |
Core A: Administrative Core |
HYMAN, BRADLEY T |
5P50AG005134-34 |
2017 |
$560124 |
5899 |
Core A: Administrative Core |
HYMAN, BRADLEY T |
5P50AG005134-34 |
2017 |
$832933 |
5900 |
Core B - Clinical Core |
GOMEZ-ISLA, TERESA |
5P50AG005134-34 |
2017 |
$214348 |
5901 |
Core C - Data Management and Statistics |
BETENSKY, REBECCA A |
5P50AG005134-34 |
2017 |
$243493 |
5902 |
Core D - Neuropathology Core |
FROSCH, MATTHEW P |
5P50AG005134-34 |
2017 |
$171505 |
5903 |
Core E - Outreach, Recruitment and Education Core |
SPERLING, REISA A. |
5P50AG005134-34 |
2017 |
$187442 |
5904 |
Core F - Neuroimaging Core |
DICKERSON, BRADFORD C |
3P50AG005134-34S2 |
2017 |
$171000 |
None |
MASSACHUSETTS ALZHEIMER'S DISEASE RESEARCH CENTER |
HYMAN, BRADLEY T |
3P50AG005134-34S1 |
2017 |
$201352 |
None |
MASSACHUSETTS ALZHEIMER'S DISEASE RESEARCH CENTER |
HYMAN, BRADLEY T |
5P50AG005134-34 |
2017 |
$222281 |
5907 |
Mouse Model of Early Alzheimers Disease |
HYMAN, BRADLEY T |
5P50AG005134-34 |
2017 |
$231732 |
5905 |
Neural Correlates of Cognitive Prodromes in Neurodegenerative Dementias |
HEDDEN, JULIUS C |
5P50AG005134-34 |
2017 |
$231732 |
5906 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
GOMEZ-ISLA, TERESA |
3P50AG005134-33S2 |
2016 |
$195601 |
None |
MASSACHUSETTS ALZHEIMER'S DISEASE RESEARCH CENTER |
HYMAN, BRADLEY T |
5P50AG005134-33 |
2016 |
$208619 |
5907 |
MOUSE MODEL OF EARLY ALZHEIMER'S DISEASE |
HYMAN, BRADLEY T |
5P50AG005134-33 |
2016 |
$217500 |
5905 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
HEDDEN, JULIUS C |
5P50AG005134-33 |
2016 |
$217500 |
5906 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
GOMEZ-ISLA, TERESA |
5P50AG005134-33 |
2016 |
$525725 |
5899 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
5P50AG005134-33 |
2016 |
$781779 |
5900 |
CORE B - CLINICAL CORE |
GOMEZ-ISLA, TERESA |
5P50AG005134-33 |
2016 |
$201184 |
5901 |
CORE C - DATA MANAGEMENT AND STATISTICS |
BETENSKY, REBECCA A |
5P50AG005134-33 |
2016 |
$228539 |
5902 |
CORE D - NEUROPATHOLOGY CORE |
FROSCH, MATTHEW P |
5P50AG005134-33 |
2016 |
$160974 |
5903 |
CORE E - OUTREACH, RECRUITMENT AND EDUCATION CORE |
SPERLING, REISA A. |
5P50AG005134-33 |
2016 |
$175930 |
5904 |
CORE F - NEUROIMAGING CORE |
SPERLING, REISA A. |
5P50AG005134-33 |
2016 |
$2717750 |
None |
MASSACHUSETTS ALZHEIMER'S DISEASE RESEARCH CENTER |
HYMAN, BRADLEY T |
3P50AG005134-33S1 |
2016 |
$177840 |
None |
MASSACHUSETTS ALZHEIMER'S DISEASE RESEARCH CENTER |
HYMAN, BRADLEY T |
5P50AG005134-32 |
2015 |
$210973 |
5905 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
HEDDEN, JULIUS C |
5P50AG005134-32 |
2015 |
$210973 |
5906 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
GOMEZ-ISLA, TERESA |
5P50AG005134-32 |
2015 |
$156145 |
5903 |
CORE E - OUTREACH; RECRUITMENT AND EDUCATION CORE |
SPERLING, REISA A. |
5P50AG005134-32 |
2015 |
$170652 |
5904 |
CORE F - NEUROIMAGING CORE |
SPERLING, REISA A. |
5P50AG005134-32 |
2015 |
$195150 |
5901 |
CORE C - DATA MANAGEMENT AND STATISTICS |
BETENSKY, REBECCA A |
5P50AG005134-32 |
2015 |
$221684 |
5902 |
CORE D - NEUROPATHOLOGY CORE |
FROSCH, MATTHEW P |
5P50AG005134-32 |
2015 |
$509954 |
5899 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
3P50AG005134-32S1 |
2015 |
$200000 |
None |
Massachusetts Alzheimers Disease Research Center |
HYMAN, BRADLEY T |
5P50AG005134-32 |
2015 |
$758327 |
5900 |
CORE B - CLINICAL CORE |
GOMEZ-ISLA, TERESA |
5P50AG005134-32 |
2015 |
$202359 |
5907 |
MOUSE MODEL OF EARLY ALZHEIMER'S DISEASE |
HYMAN, BRADLEY T |
2P50AG005134-31 |
2014 |
$525725 |
5899 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
2P50AG005134-31 |
2014 |
$781779 |
5900 |
CORE B - CLINICAL CORE |
GOMEZ-ISLA, TERESA |
2P50AG005134-31 |
2014 |
$201184 |
5901 |
CORE C - DATA MANAGEMENT AND STATISTICS |
BETENSKY, REBECCA A |
2P50AG005134-31 |
2014 |
$228539 |
5902 |
CORE D - NEUROPATHOLOGY CORE |
FROSCH, MATTHEW P |
2P50AG005134-31 |
2014 |
$160974 |
5903 |
CORE E - OUTREACH, RECRUITMENT AND EDUCATION CORE |
SPERLING, REISA A. |
2P50AG005134-31 |
2014 |
$175930 |
5904 |
CORE F - NEUROIMAGING CORE |
SPERLING, REISA A. |
2P50AG005134-31 |
2014 |
$208619 |
5907 |
MOUSE MODEL OF EARLY ALZHEIMER'S DISEASE |
HYMAN, BRADLEY T |
2P50AG005134-31 |
2014 |
$217500 |
5905 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
HEDDEN, JULIUS C |
2P50AG005134-31 |
2014 |
$217500 |
5906 |
NEURAL CORRELATES OF COGNITIVE PRODROMES IN NEURODEGENERATIVE DEMENTIAS |
GOMEZ-ISLA, TERESA |
5P50AG005134-30 |
2013 |
$111043 |
8380 |
EDUCATION AND INFORMATION TRANSFER |
LIPSITZ, LEWIS |
5P50AG005134-30 |
2013 |
$145071 |
8381 |
IMPLICATIONS OF AMYLOID DEPOSITION IN CLINICALLY NORMAL OLDER INDIVIDUALS |
SPERLING, REISA A. |
5P50AG005134-30 |
2013 |
$196437 |
8383 |
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA |
HYMAN, BRADLEY T |
5P50AG005134-30 |
2013 |
$205116 |
8379 |
NEUROPATHOLOGY |
FROSCH, MATTHEW P |
5P50AG005134-30 |
2013 |
$143893 |
8382 |
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIA |
VISWANATHAN, ANAND |
5P50AG005134-30 |
2013 |
$280831 |
6101 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
5P50AG005134-30 |
2013 |
$553860 |
8377 |
CORE B - CLINICAL CORE |
GROWDON, JOHN H |
5P50AG005134-30 |
2013 |
$170933 |
8378 |
DATA MANAGEMENT AND STATISTICS |
BETENSKY, REBECCA A |
5P50AG005134-29 |
2012 |
$328538 |
6101 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
5P50AG005134-29 |
2012 |
$640286 |
8377 |
CORE B - CLINICAL CORE |
GROWDON, JOHN H |
5P50AG005134-29 |
2012 |
$197449 |
8378 |
DATA MANAGEMENT AND STATISTICS |
BETENSKY, REBECCA A |
5P50AG005134-29 |
2012 |
$128145 |
8380 |
EDUCATION AND INFORMATION TRANSFER |
LIPSITZ, LEWIS |
5P50AG005134-29 |
2012 |
$166780 |
8381 |
IMPLICATIONS OF AMYLOID DEPOSITION IN CLINICALLY NORMAL OLDER INDIVIDUALS |
SPERLING, REISA A. |
5P50AG005134-29 |
2012 |
$227554 |
8383 |
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA |
HYMAN, BRADLEY T |
5P50AG005134-29 |
2012 |
$237478 |
8379 |
NEUROPATHOLOGY |
FROSCH, MATTHEW P |
5P50AG005134-29 |
2012 |
$165388 |
8382 |
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIA |
VISWANATHAN, ANAND |
5P50AG005134-28 |
2011 |
$119946 |
8380 |
EDUCATION AND INFORMATION TRANSFER |
LIPSITZ, LEWIS |
5P50AG005134-28 |
2011 |
$154150 |
8381 |
IMPLICATIONS OF AMYLOID DEPOSITION IN CLINICALLY NORMAL OLDER INDIVIDUALS |
SPERLING, REISA A. |
5P50AG005134-28 |
2011 |
$213070 |
8383 |
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA |
HYMAN, BRADLEY T |
5P50AG005134-28 |
2011 |
$222557 |
8379 |
NEUROPATHOLOGY |
FROSCH, MATTHEW P |
5P50AG005134-28 |
2011 |
$153848 |
8382 |
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIA |
VISWANATHAN, ANAND |
5P50AG005134-28 |
2011 |
$184613 |
8378 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
BETENSKY, REBECCA A |
5P50AG005134-28 |
2011 |
$310809 |
6101 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
5P50AG005134-28 |
2011 |
$599141 |
8377 |
CORE B - CLINICAL CORE |
GROWDON, JOHN H |
5P50AG005134-27 |
2010 |
$187462 |
8378 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
BETENSKY, REBECCA A |
5P50AG005134-27 |
2010 |
$319526 |
6101 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
5P50AG005134-27 |
2010 |
$608529 |
8377 |
CORE B - CLINICAL CORE |
GROWDON, JOHN H |
5P50AG005134-27 |
2010 |
$121803 |
8380 |
EDUCATION AND INFORMATION TRANSFER |
LIPSITZ, LEWIS |
5P50AG005134-27 |
2010 |
$156588 |
8381 |
IMPLICATIONS OF AMYLOID DEPOSITION IN CLINICALLY NORMAL OLDER INDIVIDUALS |
SPERLING, REISA A. |
5P50AG005134-27 |
2010 |
$216792 |
8383 |
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA |
HYMAN, BRADLEY T |
5P50AG005134-27 |
2010 |
$155402 |
8382 |
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIA |
VISWANATHAN, ANAND |
2P50AG005134-26 |
2009 |
$316975 |
6101 |
CORE A: ADMINISTRATIVE CORE |
HYMAN, BRADLEY T |
2P50AG005134-26 |
2009 |
$594563 |
8377 |
CORE B - CLINICAL CORE |
GROWDON, JOHN H |
2P50AG005134-26 |
2009 |
$138613 |
8380 |
EDUCATION AND INFORMATION TRANSFER |
LIPSITZ, LEWIS |
2P50AG005134-26 |
2009 |
$151800 |
8381 |
IMPLICATIONS OF AMYLOID DEPOSITION IN CLINICALLY NORMAL OLDER INDIVIDUALS |
SPERLING, REISA A. |
2P50AG005134-26 |
2009 |
$231075 |
8383 |
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA |
HYMAN, BRADLEY T |
2P50AG005134-26 |
2009 |
$151800 |
8382 |
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIA |
VISWANATHAN, ANAND |
2P50AG005134-26 |
2009 |
$183172 |
8378 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
BETENSKY, REBECCA A |
5P50AG005134-25 |
2008 |
$453454 |
9001 |
CORE--CLINICAL GENETIC & NEUROIMAGING |
GROWDON, JOHN H |
5P50AG005134-25 |
2008 |
$153768 |
9005 |
CORE--DATABASE MANAGEMENT AND STATISTICS |
SCHOENFELD, DAVID ALAN |
5P50AG005134-25 |
2008 |
$318376 |
9004 |
CORE--EDUCATION AND INFORMATION TRANSFER |
LIPSITZ, LEWIS |
5P50AG005134-25 |
2008 |
$181975 |
26 |
PHOSPHORYLATION CONTROL OF TAU NEUROTOXICITY IN DROSOPHILA |
FEANY, MEL B |
5P50AG005134-25 |
2008 |
$338459 |
27 |
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS |
HYMAN, BRADLEY T |